Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 35,484	$ 33,461
Short term investments, net	118,715	96,445
Accounts receivable, net	103	205
Accounts receivable, net - related parties	2,021	1,768
Inventory, net	7,257	6,316
Prepaid expenses and other current assets	5,714	6,218
Total current assets	169,294	144,413
Option	101	239
Deposits and other assets	3,241	1,086
Long term investments, net	8,851	51,882
Property and equipment, net	1,183	1,308
Total assets	182,670	198,928
Current liabilities:
Accounts payable	684	1,204
Accrued expenses and other current liabilities	12,674	10,667
Accrued expenses and other current liabilities- related parties	671	3,597
Note payable, current portion, net	15,223
Derivative liability, current portion	328
Option, current	28,068
Term Loans, net		2,926
Total current liabilities	57,648	18,394
Long-term debt and notes payables, net	53,434	59,798
Derivative liabilities	83,794	236,291
Option		69,401
Other liabilities	2,859	579
Total liabilities	197,735	384,463
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.001 par value per share; 900,000,000 shares authorized as of September 30, 2022 and December 31, 2021; 478,211,956 shares and 447,282,263 shares issued and outstanding as of September 30, 2022 and December 31, 2021	478	447
Additional paid-in capital	806,069	765,215
Accumulated other comprehensive loss	(1,185)	(212)
Accumulated deficit	(820,427)	(950,985)
Total stockholders' equity (deficit)	(15,065)	(185,535)
Total liabilities and stockholders' equity (deficit)	$ 182,670	$ 198,928